Severe Dyslipidemia in LATAM: Confronting the Future

Introduction to Forum 1

Featuring Rodrigo Alonso, MD, PhD

Diagnosis & Natural History of Familial Chylomicronemia Syndrome

Featuring Maria Cristina Izar, MD

Epidemiology & Genetics of Severe Forms of Hypertriglyceridemias

Featuring Robert Hegele, MD

Lipodystrophies & Severe Hypertriglyceridemia

Featuring Renan Montenegro, MD

Lipoprotein Lipase Activity & Its Regulation

Featuring Juan Patricio Nogueira, MD

Severe Dyslipidemia in LATAM: Confronting the Future – Chile Perspective

Featuring Ada Cuevas, MD, MSc

Forum 1 Summary

Featuring Rodrigo Alonso, MD, PhD, & Ada Cuevas, MD, MSc

Triglyceride-Rich Lipoproteins & Atherosclerosis

Featuring Rodrigo Alonso, MD, PhD

Management of Severe Hypertriglyceridaemia

Featuring Dirk Blom, MBChB, MMed

Severe Dyslipidemia in LATAM: Confronting the Future – Brazil Perspective

Featuring Viviane Rocha Giraldez, MD

Forum 2 Summary

Featuring Raul Santos, MD,PhD, & Viviane Rocha Giraldez, MD

Forum 3 Introduction

Featuring Juan Patricio Nogueira, MD

Genetics of Hypercholesterolemia with a Focus on Monogenic Forms

Featuring Robert Hegele, MD

Natural History of Homozygous FH and its Epidemiology in LATAM

Featuring Rodrigo Alonso, MD, PhD

Defining the Severe FH Phenotype and its Implications

Featuring Raul Santos, MD, PhD

Severe Dyslipidemia in LATAM: Confronting the Future – Argentina Perspective

Featuring Pablo Corral, MD

Forum 3 Summary

Featuring Juan Patricio Nogueira, MD, & Pablo Corral, MD

Forum 4 Introduction

Featuring Maria Cristina Izar, MD

PCSK9 Inhibitors in Severe FH

Featuring Maria Cristina Izar, MD

Severe Pediatric Hypercholesterolemia

Featuring Samuel Gidding, MD

Lomitapide Efficacy and Safety in Homozygous FH

Featuring Dirk Blom, MBChB, MMed

Novel Therapies for Severe FH

Featuring Paola Varleta, MD

Severe Dyslipidemia in LATAM: Confronting the Future – Mexico Perspective

Featuring Roopa Mehta, MD

Forum 4 Summary

Featuring Maria Cristina Izar, MD, & Roopa Mehta, MD